THORAC-话题@MedSci

#THORAC#

175篇内容 | 3597人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2057095, encodeId=86d8205e09522, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=Thorac Cancer：Anlotinib（安罗替尼）治疗小细胞肺癌伴有胸腔积液患者的疗效和安全性, objectType=article, longId=221642, objectId=5305221642d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5305221642d2, replyNumber=0, likeNumber=66, createdTime=2022-02-06, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5305221642d2, moduleTitle=Thorac Cancer：Anlotinib（安罗替尼）治疗小细胞肺癌伴有胸腔积液患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5305221642d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057077, encodeId=fa12205e0779b, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol：Sintilimab联合化疗可显著延长非鳞状NSCLC患者的总生存期！, objectType=article, longId=215518, objectId=62cd2155186f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62cd2155186f, replyNumber=0, likeNumber=86, createdTime=2022-02-11, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62cd2155186f, moduleTitle=J Thorac Oncol：Sintilimab联合化疗可显著延长非鳞状NSCLC患者的总生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62cd2155186f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057079, encodeId=0fea205e07933, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol：达拉非尼+曲美替尼治疗转移性BRAF V600E突变非小细胞肺癌的疗效：5年生存结果更新, objectType=article, longId=217037, objectId=f9ca21e03751, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ca21e03751, replyNumber=0, likeNumber=53, createdTime=2022-03-14, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ca21e03751, moduleTitle=J Thorac Oncol：达拉非尼+曲美替尼治疗转移性BRAF V600E突变非小细胞肺癌的疗效：5年生存结果更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ca21e03751)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057072, encodeId=89fb205e072b9, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol: 吉非替尼联合同步放疗治疗EGFR突变阳性的局部进展非小细胞肺癌（LA-NSCLC）患者的疗效和安全性：日本西部肿瘤组6911L, objectType=article, longId=213145, objectId=141f2131458b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=141f2131458b, replyNumber=0, likeNumber=109, createdTime=2022-02-26, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=141f2131458b, moduleTitle=J Thorac Oncol: 吉非替尼联合同步放疗治疗EGFR突变阳性的局部进展非小细胞肺癌（LA-NSCLC）患者的疗效和安全性：日本西部肿瘤组6911L, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=141f2131458b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057092, encodeId=1f0e205e092a5, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol：Aumolertinib(HS-10296)治疗EGFR-T790M+晚期NSCLC患者的疗效和安全性：APOLLO研究, objectType=article, longId=221184, objectId=7716221184e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7716221184e3, replyNumber=0, likeNumber=46, createdTime=2022-08-08, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7716221184e3, moduleTitle=J Thorac Oncol：Aumolertinib(HS-10296)治疗EGFR-T790M+晚期NSCLC患者的疗效和安全性：APOLLO研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7716221184e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057094, encodeId=b050205e094f9, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=Thorac Cancer：多中心回顾性研究比较pembrolizumab单药或联合化疗治疗非小细胞肺癌的疗效, objectType=article, longId=221635, objectId=7c93221635a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c93221635a0, replyNumber=0, likeNumber=88, createdTime=2022-11-02, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c93221635a0, moduleTitle=Thorac Cancer：多中心回顾性研究比较pembrolizumab单药或联合化疗治疗非小细胞肺癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c93221635a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057093, encodeId=99b1205e0936b, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=Thorac Cancer：克唑替尼-阿来替尼续贯方案治疗中国晚期ALK阳性NSCLC患者的疗效, objectType=article, longId=221572, objectId=bfd12215e24f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfd12215e24f, replyNumber=0, likeNumber=86, createdTime=2022-11-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfd12215e24f, moduleTitle=Thorac Cancer：克唑替尼-阿来替尼续贯方案治疗中国晚期ALK阳性NSCLC患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfd12215e24f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057102, encodeId=ee11205e10298, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=Thorac Cancer：广泛期小细胞肺癌(ED-SCLC)患者标准一线化疗治疗后使用阿帕替尼维持治疗可进一步延长生存, objectType=article, longId=294109, objectId=be7a294109e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be7a294109e3, replyNumber=0, likeNumber=94, createdTime=2022-01-19, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be7a294109e3, moduleTitle=Thorac Cancer：广泛期小细胞肺癌(ED-SCLC)患者标准一线化疗治疗后使用阿帕替尼维持治疗可进一步延长生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be7a294109e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057083, encodeId=6c2c205e08373, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol: RNA深度测序显示融合异质性可预测克唑替尼对ALK重排非小细胞肺癌的治疗效果, objectType=article, longId=218427, objectId=9f9321842e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f9321842e08, replyNumber=0, likeNumber=56, createdTime=2022-05-08, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f9321842e08, moduleTitle=J Thorac Oncol: RNA深度测序显示融合异质性可预测克唑替尼对ALK重排非小细胞肺癌的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f9321842e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057087, encodeId=7d9e205e08773, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=Thorac Cancer：真实世界中dacomitinib（达可替尼）治疗伴有脑转移的EGFR突变阳性NSCLC患者的疗效, objectType=article, longId=220889, objectId=d4ae2208892d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4ae2208892d, replyNumber=0, likeNumber=143, createdTime=2022-02-12, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4ae2208892d, moduleTitle=Thorac Cancer：真实世界中dacomitinib（达可替尼）治疗伴有脑转移的EGFR突变阳性NSCLC患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4ae2208892d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057101, encodeId=b08d205e10101, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol: 第三代EGFR-TKI lazertinib治疗T790m突变NSCLC患者疗效显著且安全可控, objectType=article, longId=293988, objectId=5aae293988cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5aae293988cd, replyNumber=0, likeNumber=103, createdTime=2022-05-11, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5aae293988cd, moduleTitle=J Thorac Oncol: 第三代EGFR-TKI lazertinib治疗T790m突变NSCLC患者疗效显著且安全可控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5aae293988cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057059, encodeId=3346205e05927, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol：RovalPituzumab tesiine与拓扑替康用作小细胞肺癌二线治疗方案的疗效对比, objectType=article, longId=207881, objectId=1b2f20e88186, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b2f20e88186, replyNumber=0, likeNumber=97, createdTime=2021-07-25, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b2f20e88186, moduleTitle=J Thorac Oncol：RovalPituzumab tesiine与拓扑替康用作小细胞肺癌二线治疗方案的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b2f20e88186)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057089, encodeId=c4de205e08957, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效, objectType=article, longId=220996, objectId=8ab722099677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab722099677, replyNumber=0, likeNumber=91, createdTime=2022-06-26, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab722099677, moduleTitle=Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab722099677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057078, encodeId=9b11205e07869, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Onco：奥希替尼单药抗NSCLC患者未放疗过的CNS转移灶的疗效, objectType=article, longId=216361, objectId=29db21636143, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29db21636143, replyNumber=0, likeNumber=72, createdTime=2022-01-26, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29db21636143, moduleTitle=J Thorac Onco：奥希替尼单药抗NSCLC患者未放疗过的CNS转移灶的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29db21636143)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057060, encodeId=4a48205e06015, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Cardiothorac Surg：早期口服母乳刺激有益于先心病术后婴儿早期喂养行为的建立, objectType=article, longId=209901, objectId=ed16209901ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed16209901ec, replyNumber=0, likeNumber=72, createdTime=2021-07-23, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed16209901ec, moduleTitle=J Cardiothorac Surg：早期口服母乳刺激有益于先心病术后婴儿早期喂养行为的建立, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed16209901ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057075, encodeId=c822205e075ee, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol：17年来，NSCLC病理报告的准确性和完整性随时间的变化, objectType=article, longId=214566, objectId=580421456629, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=580421456629, replyNumber=0, likeNumber=76, createdTime=2021-09-15, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=580421456629, moduleTitle=J Thorac Oncol：17年来，NSCLC病理报告的准确性和完整性随时间的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=580421456629)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057076, encodeId=2a95205e07658, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol:阿替利珠单抗（atezolizumab）联合贝伐珠单抗+化疗一线治疗转移性非鳞状非小细胞肺癌的最终OS分析：IMpower150, objectType=article, longId=214763, objectId=e0a7214e632f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0a7214e632f, replyNumber=0, likeNumber=84, createdTime=2022-04-08, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0a7214e632f, moduleTitle=J Thorac Oncol:阿替利珠单抗（atezolizumab）联合贝伐珠单抗+化疗一线治疗转移性非鳞状非小细胞肺癌的最终OS分析：IMpower150, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0a7214e632f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057085, encodeId=4dc8205e085f6, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol：ADAURA研究：IB-IIIA期EGFR突变阳性NSCLC切除术后使用奥希替尼辅助治疗改善患者DFS，无论是否接受辅助化疗, objectType=article, longId=220083, objectId=ae6a2200837d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae6a2200837d, replyNumber=0, likeNumber=61, createdTime=2022-01-21, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae6a2200837d, moduleTitle=J Thorac Oncol：ADAURA研究：IB-IIIA期EGFR突变阳性NSCLC切除术后使用奥希替尼辅助治疗改善患者DFS，无论是否接受辅助化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae6a2200837d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057080, encodeId=cd57205e08042, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效 , objectType=article, longId=217043, objectId=644421e04318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=644421e04318, replyNumber=0, likeNumber=102, createdTime=2022-08-01, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=644421e04318, moduleTitle=J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=644421e04318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057070, encodeId=c83b205e07007, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, objectTitle=Journal of Cardiothoracic Surgery：900万人研究！冠脉搭桥术后30天再入院率及风险因素, objectType=article, longId=212843, objectId=c507212843f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c507212843f7, replyNumber=0, likeNumber=63, createdTime=2022-01-09, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c507212843f7, moduleTitle=Journal of Cardiothoracic Surgery：900万人研究！冠脉搭桥术后30天再入院率及风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c507212843f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

THORAC

2020-05-29

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

Thorac Cancer：Anlotinib（安罗替尼）治疗小细胞肺癌伴有胸腔积液患者的疗效和安全性

2022-02-06

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol：Sintilimab联合化疗可显著延长非鳞状NSCLC患者的总生存期！

2022-02-11

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol：达拉非尼+曲美替尼治疗转移性BRAF V600E突变非小细胞肺癌的疗效：5年生存结果更新

2022-03-14

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol: 吉非替尼联合同步放疗治疗EGFR突变阳性的局部进展非小细胞肺癌（LA-NSCLC）患者的疗效和安全性：日本西部肿瘤组6911L

2022-02-26

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol：Aumolertinib(HS-10296)治疗EGFR-T790M+晚期NSCLC患者的疗效和安全性：APOLLO研究

2022-08-08

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

Thorac Cancer：多中心回顾性研究比较pembrolizumab单药或联合化疗治疗非小细胞肺癌的疗效

2022-11-02

hb2008ye (审核中...)

前往app查看评论内容

#THORAC#

Thorac Cancer：克唑替尼-阿来替尼续贯方案治疗中国晚期ALK阳性NSCLC患者的疗效

2022-11-11

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

Thorac Cancer：广泛期小细胞肺癌(ED-SCLC)患者标准一线化疗治疗后使用阿帕替尼维持治疗可进一步延长生存

2022-01-19

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol: RNA深度测序显示融合异质性可预测克唑替尼对ALK重排非小细胞肺癌的治疗效果

2022-05-08

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

Thorac Cancer：真实世界中dacomitinib（达可替尼）治疗伴有脑转移的EGFR突变阳性NSCLC患者的疗效

2022-02-12

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol: 第三代EGFR-TKI lazertinib治疗T790m突变NSCLC患者疗效显著且安全可控

2022-05-11

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol：RovalPituzumab tesiine与拓扑替康用作小细胞肺癌二线治疗方案的疗效对比

2021-07-25

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效

2022-06-26

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Onco：奥希替尼单药抗NSCLC患者未放疗过的CNS转移灶的疗效

2022-01-26

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Cardiothorac Surg：早期口服母乳刺激有益于先心病术后婴儿早期喂养行为的建立

2021-07-23

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol：17年来，NSCLC病理报告的准确性和完整性随时间的变化

2021-09-15

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol:阿替利珠单抗（atezolizumab）联合贝伐珠单抗+化疗一线治疗转移性非鳞状非小细胞肺癌的最终OS分析：IMpower150

2022-04-08

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol：ADAURA研究：IB-IIIA期EGFR突变阳性NSCLC切除术后使用奥希替尼辅助治疗改善患者DFS，无论是否接受辅助化疗

2022-01-21

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效

2022-08-01

yyj062 (审核中...)

前往app查看评论内容

#THORAC#

Journal of Cardiothoracic Surgery：900万人研究！冠脉搭桥术后30天再入院率及风险因素

2022-01-09

科室
- - 订阅+
  - 更多科室
工具
服务